|Articles|January 1, 2004
- Pharmaceutical Executive-01-01-2004
Table of Contents
Table of Contents
Advertisement
Articles in this issue
almost 22 years ago
PE's Annual Sales and Marketing Employment Survey: The Big Squeezealmost 22 years ago
Streamlining For Success with Fred Price of BioMarinalmost 22 years ago
The Making of a New DiseaseNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Trending on PharmExec
1
Report: Richard Pazdur Out as Director of CDER
2
Pharmaceutical Commercialization: A 2026 Outlook Personalization and Precision Will Define a New Year in Pharma
3
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
4
Regeneron Announces $150 Million Collaboration with Tessera Therapeutics to Develop Gene Editing Therapy
5
